Search for: "Lewis v. Lee" Results 281 - 297 of 297
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2023, 9:01 pm by renholding
There is reason to believe the SEC’s new universal proxy Rule 14a-19 will result in more stockholder nominees being elected to the boards of public companies. [read post]
15 Nov 2007, 7:21 am
Phone: (404) 881-0292 Fax: (404) 881-6997 E-mail: gaaarp@aarp.org Web: http://www.aarp.orgga ADA Regional ADA & IT Technical Assistance Center Southeast Disability and Business Technical Assistance Center Center for Assistive Technology and Environmental Access Georgia Tech, 490 10th Street Atlanta, GA 30318 Phone: (404) 385-0636; (800) 949-4232 (V/TTY/Toll Free) E-mail: sedbtac@catea.org Web: http://www.sedbtac.org Georgia ADA Exchange 4164 Admiral Drive Chamblee, GA 30341… [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
9 Sep 2011, 8:40 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
2 Oct 2010, 8:43 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
11 Feb 2011, 7:51 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
30 May 2012, 1:37 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
22 Jun 2011, 7:09 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
12 Mar 2012, 8:13 am by Ronald Collins
In December 1833, the American Monthly Review commented on a newly published book by Joseph Story. [read post]
10 May 2010, 1:16 pm by admin
The following is a summary review of articles from all over the nation concerning environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]